nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A4—Fingolimod—multiple sclerosis	0.047	0.135	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0392	0.113	CbGbCtD
Triazolam—CYP3A7—Dexamethasone—multiple sclerosis	0.0392	0.113	CbGbCtD
Triazolam—CYP3A4—Methylprednisolone—multiple sclerosis	0.0303	0.0873	CbGbCtD
Triazolam—CYP3A5—Dexamethasone—multiple sclerosis	0.0294	0.0847	CbGbCtD
Triazolam—CYP2C8—Dexamethasone—multiple sclerosis	0.0283	0.0814	CbGbCtD
Triazolam—CYP3A4—Triamcinolone—multiple sclerosis	0.023	0.0661	CbGbCtD
Triazolam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0221	0.0637	CbGbCtD
Triazolam—CYP2C9—Dexamethasone—multiple sclerosis	0.0197	0.0568	CbGbCtD
Triazolam—CYP3A4—Betamethasone—multiple sclerosis	0.0197	0.0568	CbGbCtD
Triazolam—CYP3A4—Prednisolone—multiple sclerosis	0.0194	0.056	CbGbCtD
Triazolam—CYP3A4—Prednisone—multiple sclerosis	0.0184	0.0529	CbGbCtD
Triazolam—GABRR3—peripheral nervous system—multiple sclerosis	0.0174	0.0593	CbGeAlD
Triazolam—GABRR2—peripheral nervous system—multiple sclerosis	0.0151	0.0514	CbGeAlD
Triazolam—GABRR1—peripheral nervous system—multiple sclerosis	0.0145	0.0495	CbGeAlD
Triazolam—GABRR3—nerve—multiple sclerosis	0.0136	0.0462	CbGeAlD
Triazolam—GABRQ—nerve—multiple sclerosis	0.0136	0.0462	CbGeAlD
Triazolam—GABRR2—nerve—multiple sclerosis	0.0118	0.0401	CbGeAlD
Triazolam—CYP3A4—Dexamethasone—multiple sclerosis	0.0115	0.033	CbGbCtD
Triazolam—GABRR1—nerve—multiple sclerosis	0.0113	0.0386	CbGeAlD
Triazolam—GABRR3—retina—multiple sclerosis	0.00561	0.0191	CbGeAlD
Triazolam—GABRR2—retina—multiple sclerosis	0.00487	0.0166	CbGeAlD
Triazolam—GABRR1—retina—multiple sclerosis	0.00469	0.016	CbGeAlD
Triazolam—GABRA6—brainstem—multiple sclerosis	0.00404	0.0138	CbGeAlD
Triazolam—GABRR3—nervous system—multiple sclerosis	0.00305	0.0104	CbGeAlD
Triazolam—GABRQ—nervous system—multiple sclerosis	0.00305	0.0104	CbGeAlD
Triazolam—GABRB2—brainstem—multiple sclerosis	0.00297	0.0101	CbGeAlD
Triazolam—GABRD—medulla oblongata—multiple sclerosis	0.00294	0.01	CbGeAlD
Triazolam—GABRQ—central nervous system—multiple sclerosis	0.00294	0.01	CbGeAlD
Triazolam—GABRG1—medulla oblongata—multiple sclerosis	0.00283	0.00966	CbGeAlD
Triazolam—GABRB1—medulla oblongata—multiple sclerosis	0.00275	0.00936	CbGeAlD
Triazolam—GABRA2—brainstem—multiple sclerosis	0.00272	0.00926	CbGeAlD
Triazolam—GABRD—midbrain—multiple sclerosis	0.00269	0.00917	CbGeAlD
Triazolam—GABRG3—nervous system—multiple sclerosis	0.00267	0.0091	CbGeAlD
Triazolam—GABRR2—nervous system—multiple sclerosis	0.00264	0.00901	CbGeAlD
Triazolam—GABRA1—brainstem—multiple sclerosis	0.00263	0.00895	CbGeAlD
Triazolam—GABRG1—midbrain—multiple sclerosis	0.00259	0.00883	CbGeAlD
Triazolam—GABRG3—central nervous system—multiple sclerosis	0.00257	0.00876	CbGeAlD
Triazolam—GABRR1—nervous system—multiple sclerosis	0.00254	0.00867	CbGeAlD
Triazolam—GABRG1—spinal cord—multiple sclerosis	0.00253	0.00861	CbGeAlD
Triazolam—TSPO—brainstem—multiple sclerosis	0.00251	0.00857	CbGeAlD
Triazolam—GABRB1—midbrain—multiple sclerosis	0.00251	0.00856	CbGeAlD
Triazolam—GABRR2—cerebellum—multiple sclerosis	0.00249	0.00848	CbGeAlD
Triazolam—GABRR1—central nervous system—multiple sclerosis	0.00245	0.00835	CbGeAlD
Triazolam—GABRB1—spinal cord—multiple sclerosis	0.00245	0.00835	CbGeAlD
Triazolam—TSPO—retina—multiple sclerosis	0.00243	0.00827	CbGeAlD
Triazolam—GABRQ—brain—multiple sclerosis	0.00233	0.00794	CbGeAlD
Triazolam—GABRD—nervous system—multiple sclerosis	0.00221	0.00754	CbGeAlD
Triazolam—GABRD—central nervous system—multiple sclerosis	0.00213	0.00726	CbGeAlD
Triazolam—GABRG1—nervous system—multiple sclerosis	0.00213	0.00726	CbGeAlD
Triazolam—GABRA6—nervous system—multiple sclerosis	0.00212	0.00721	CbGeAlD
Triazolam—GABRD—cerebellum—multiple sclerosis	0.00208	0.00709	CbGeAlD
Triazolam—GABRG2—medulla oblongata—multiple sclerosis	0.00207	0.00707	CbGeAlD
Triazolam—GABRB2—medulla oblongata—multiple sclerosis	0.00207	0.00707	CbGeAlD
Triazolam—GABRB1—nervous system—multiple sclerosis	0.00206	0.00704	CbGeAlD
Triazolam—GABRA5—nervous system—multiple sclerosis	0.00205	0.007	CbGeAlD
Triazolam—GABRG1—central nervous system—multiple sclerosis	0.00205	0.00699	CbGeAlD
Triazolam—GABRG3—brain—multiple sclerosis	0.00204	0.00696	CbGeAlD
Triazolam—GABRA6—central nervous system—multiple sclerosis	0.00204	0.00695	CbGeAlD
Triazolam—GABRG1—cerebellum—multiple sclerosis	0.002	0.00683	CbGeAlD
Triazolam—GABRA6—cerebellum—multiple sclerosis	0.00199	0.00679	CbGeAlD
Triazolam—GABRB1—central nervous system—multiple sclerosis	0.00199	0.00677	CbGeAlD
Triazolam—GABRA5—central nervous system—multiple sclerosis	0.00198	0.00674	CbGeAlD
Triazolam—GABRR1—brain—multiple sclerosis	0.00194	0.00663	CbGeAlD
Triazolam—GABRB1—cerebellum—multiple sclerosis	0.00194	0.00662	CbGeAlD
Triazolam—GABRA3—nervous system—multiple sclerosis	0.00191	0.00652	CbGeAlD
Triazolam—GABRB2—midbrain—multiple sclerosis	0.0019	0.00646	CbGeAlD
Triazolam—GABRG2—midbrain—multiple sclerosis	0.0019	0.00646	CbGeAlD
Triazolam—GABRA4—nervous system—multiple sclerosis	0.00186	0.00635	CbGeAlD
Triazolam—GABRB2—spinal cord—multiple sclerosis	0.00185	0.0063	CbGeAlD
Triazolam—GABRG2—spinal cord—multiple sclerosis	0.00185	0.0063	CbGeAlD
Triazolam—GABRA3—central nervous system—multiple sclerosis	0.00184	0.00627	CbGeAlD
Triazolam—GABRA1—medulla oblongata—multiple sclerosis	0.00183	0.00624	CbGeAlD
Triazolam—GABRA4—central nervous system—multiple sclerosis	0.00179	0.00611	CbGeAlD
Triazolam—TSPO—medulla oblongata—multiple sclerosis	0.00175	0.00598	CbGeAlD
Triazolam—GABRA4—cerebellum—multiple sclerosis	0.00175	0.00597	CbGeAlD
Triazolam—GABRD—brain—multiple sclerosis	0.00169	0.00576	CbGeAlD
Triazolam—GABRA1—midbrain—multiple sclerosis	0.00167	0.0057	CbGeAlD
Triazolam—GABRA1—spinal cord—multiple sclerosis	0.00163	0.00557	CbGeAlD
Triazolam—GABRG1—brain—multiple sclerosis	0.00163	0.00555	CbGeAlD
Triazolam—GABRA6—brain—multiple sclerosis	0.00162	0.00551	CbGeAlD
Triazolam—TSPO—midbrain—multiple sclerosis	0.0016	0.00546	CbGeAlD
Triazolam—GABRB3—medulla oblongata—multiple sclerosis	0.00159	0.00543	CbGeAlD
Triazolam—GABRB1—brain—multiple sclerosis	0.00158	0.00538	CbGeAlD
Triazolam—GABRA5—brain—multiple sclerosis	0.00157	0.00535	CbGeAlD
Triazolam—TSPO—spinal cord—multiple sclerosis	0.00156	0.00533	CbGeAlD
Triazolam—GABRG2—nervous system—multiple sclerosis	0.00156	0.00531	CbGeAlD
Triazolam—GABRB2—nervous system—multiple sclerosis	0.00156	0.00531	CbGeAlD
Triazolam—GABRG2—central nervous system—multiple sclerosis	0.0015	0.00511	CbGeAlD
Triazolam—GABRB2—central nervous system—multiple sclerosis	0.0015	0.00511	CbGeAlD
Triazolam—GABRB2—cerebellum—multiple sclerosis	0.00147	0.005	CbGeAlD
Triazolam—GABRG2—cerebellum—multiple sclerosis	0.00147	0.005	CbGeAlD
Triazolam—GABRA3—brain—multiple sclerosis	0.00146	0.00498	CbGeAlD
Triazolam—GABRB3—midbrain—multiple sclerosis	0.00146	0.00496	CbGeAlD
Triazolam—GABRA4—brain—multiple sclerosis	0.00142	0.00485	CbGeAlD
Triazolam—GABRA2—nervous system—multiple sclerosis	0.00142	0.00485	CbGeAlD
Triazolam—GABRB3—spinal cord—multiple sclerosis	0.00142	0.00484	CbGeAlD
Triazolam—GABRE—nervous system—multiple sclerosis	0.00141	0.00481	CbGeAlD
Triazolam—GABRA1—nervous system—multiple sclerosis	0.00138	0.00469	CbGeAlD
Triazolam—GABRA2—central nervous system—multiple sclerosis	0.00137	0.00467	CbGeAlD
Triazolam—GABRE—central nervous system—multiple sclerosis	0.00136	0.00463	CbGeAlD
Triazolam—GABRA2—cerebellum—multiple sclerosis	0.00134	0.00457	CbGeAlD
Triazolam—GABRA1—central nervous system—multiple sclerosis	0.00132	0.00451	CbGeAlD
Triazolam—TSPO—nervous system—multiple sclerosis	0.00132	0.00449	CbGeAlD
Triazolam—GABRA1—cerebellum—multiple sclerosis	0.00129	0.00441	CbGeAlD
Triazolam—TSPO—central nervous system—multiple sclerosis	0.00127	0.00432	CbGeAlD
Triazolam—TSPO—cerebellum—multiple sclerosis	0.00124	0.00423	CbGeAlD
Triazolam—GABRB3—nervous system—multiple sclerosis	0.0012	0.00408	CbGeAlD
Triazolam—GABRG2—brain—multiple sclerosis	0.00119	0.00406	CbGeAlD
Triazolam—GABRB2—brain—multiple sclerosis	0.00119	0.00406	CbGeAlD
Triazolam—GABRB3—central nervous system—multiple sclerosis	0.00115	0.00393	CbGeAlD
Triazolam—GABRB3—cerebellum—multiple sclerosis	0.00113	0.00384	CbGeAlD
Triazolam—GABRA2—brain—multiple sclerosis	0.00109	0.00371	CbGeAlD
Triazolam—GABRE—brain—multiple sclerosis	0.00108	0.00368	CbGeAlD
Triazolam—GABRA1—brain—multiple sclerosis	0.00105	0.00358	CbGeAlD
Triazolam—TSPO—brain—multiple sclerosis	0.00101	0.00343	CbGeAlD
Triazolam—GABRB3—brain—multiple sclerosis	0.000914	0.00312	CbGeAlD
Triazolam—Hallucination—Methylprednisolone—multiple sclerosis	0.000847	0.00245	CcSEcCtD
Triazolam—Chest pain—Mitoxantrone—multiple sclerosis	0.000838	0.00243	CcSEcCtD
Triazolam—Diarrhoea—Cladribine—multiple sclerosis	0.000836	0.00242	CcSEcCtD
Triazolam—Anxiety—Mitoxantrone—multiple sclerosis	0.000835	0.00242	CcSEcCtD
Triazolam—Discomfort—Mitoxantrone—multiple sclerosis	0.000828	0.0024	CcSEcCtD
Triazolam—Sweating increased—Prednisone—multiple sclerosis	0.00082	0.00238	CcSEcCtD
Triazolam—Visual impairment—Methylprednisolone—multiple sclerosis	0.00082	0.00238	CcSEcCtD
Triazolam—Feeling abnormal—Azathioprine—multiple sclerosis	0.000819	0.00237	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—multiple sclerosis	0.000814	0.00236	CcSEcCtD
Triazolam—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000813	0.00235	CcSEcCtD
Triazolam—Confusional state—Mitoxantrone—multiple sclerosis	0.00081	0.00235	CcSEcCtD
Triazolam—Dizziness—Cladribine—multiple sclerosis	0.000808	0.00234	CcSEcCtD
Triazolam—Erythema—Prednisolone—multiple sclerosis	0.000807	0.00234	CcSEcCtD
Triazolam—Oedema—Mitoxantrone—multiple sclerosis	0.000803	0.00233	CcSEcCtD
Triazolam—Shock—Mitoxantrone—multiple sclerosis	0.00079	0.00229	CcSEcCtD
Triazolam—Abdominal pain—Azathioprine—multiple sclerosis	0.000786	0.00228	CcSEcCtD
Triazolam—Tachycardia—Mitoxantrone—multiple sclerosis	0.000784	0.00227	CcSEcCtD
Triazolam—Irritability—Methotrexate—multiple sclerosis	0.000777	0.00225	CcSEcCtD
Triazolam—Vomiting—Cladribine—multiple sclerosis	0.000777	0.00225	CcSEcCtD
Triazolam—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000777	0.00225	CcSEcCtD
Triazolam—Mood swings—Methotrexate—multiple sclerosis	0.000771	0.00223	CcSEcCtD
Triazolam—Hallucination—Dexamethasone—multiple sclerosis	0.00077	0.00223	CcSEcCtD
Triazolam—Hallucination—Betamethasone—multiple sclerosis	0.00077	0.00223	CcSEcCtD
Triazolam—Dermatitis—Cladribine—multiple sclerosis	0.00077	0.00223	CcSEcCtD
Triazolam—Anorexia—Mitoxantrone—multiple sclerosis	0.000766	0.00222	CcSEcCtD
Triazolam—Ataxia—Methotrexate—multiple sclerosis	0.000766	0.00222	CcSEcCtD
Triazolam—Headache—Cladribine—multiple sclerosis	0.000766	0.00222	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000749	0.00217	CcSEcCtD
Triazolam—Visual impairment—Dexamethasone—multiple sclerosis	0.000746	0.00216	CcSEcCtD
Triazolam—Visual impairment—Betamethasone—multiple sclerosis	0.000746	0.00216	CcSEcCtD
Triazolam—Erythema—Triamcinolone—multiple sclerosis	0.000743	0.00215	CcSEcCtD
Triazolam—Erythema—Methylprednisolone—multiple sclerosis	0.000741	0.00215	CcSEcCtD
Triazolam—Hypersensitivity—Azathioprine—multiple sclerosis	0.000732	0.00212	CcSEcCtD
Triazolam—Malaise—Prednisolone—multiple sclerosis	0.000728	0.00211	CcSEcCtD
Triazolam—Dysgeusia—Triamcinolone—multiple sclerosis	0.000727	0.00211	CcSEcCtD
Triazolam—Nausea—Cladribine—multiple sclerosis	0.000726	0.0021	CcSEcCtD
Triazolam—Syncope—Prednisolone—multiple sclerosis	0.000724	0.0021	CcSEcCtD
Triazolam—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000721	0.00209	CcSEcCtD
Triazolam—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000716	0.00207	CcSEcCtD
Triazolam—Somnolence—Mitoxantrone—multiple sclerosis	0.000714	0.00207	CcSEcCtD
Triazolam—Loss of consciousness—Prednisolone—multiple sclerosis	0.00071	0.00206	CcSEcCtD
Triazolam—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000698	0.00202	CcSEcCtD
Triazolam—Hypertension—Prednisolone—multiple sclerosis	0.000697	0.00202	CcSEcCtD
Triazolam—Fatigue—Mitoxantrone—multiple sclerosis	0.000693	0.00201	CcSEcCtD
Triazolam—CYP2C8—brain—multiple sclerosis	0.000691	0.00236	CbGeAlD
Triazolam—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000689	0.002	CcSEcCtD
Triazolam—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000687	0.00199	CcSEcCtD
Triazolam—Pain—Mitoxantrone—multiple sclerosis	0.000687	0.00199	CcSEcCtD
Triazolam—Constipation—Mitoxantrone—multiple sclerosis	0.000687	0.00199	CcSEcCtD
Triazolam—Diarrhoea—Azathioprine—multiple sclerosis	0.00068	0.00197	CcSEcCtD
Triazolam—Discomfort—Prednisolone—multiple sclerosis	0.000679	0.00197	CcSEcCtD
Triazolam—Erythema—Dexamethasone—multiple sclerosis	0.000674	0.00195	CcSEcCtD
Triazolam—Erythema—Betamethasone—multiple sclerosis	0.000674	0.00195	CcSEcCtD
Triazolam—Hallucination—Prednisone—multiple sclerosis	0.000671	0.00194	CcSEcCtD
Triazolam—Malaise—Triamcinolone—multiple sclerosis	0.00067	0.00194	CcSEcCtD
Triazolam—Malaise—Methylprednisolone—multiple sclerosis	0.000668	0.00194	CcSEcCtD
Triazolam—Syncope—Triamcinolone—multiple sclerosis	0.000666	0.00193	CcSEcCtD
Triazolam—Syncope—Methylprednisolone—multiple sclerosis	0.000664	0.00192	CcSEcCtD
Triazolam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000662	0.00192	CcSEcCtD
Triazolam—Oedema—Prednisolone—multiple sclerosis	0.000659	0.00191	CcSEcCtD
Triazolam—Dysuria—Methotrexate—multiple sclerosis	0.000658	0.00191	CcSEcCtD
Triazolam—Dizziness—Azathioprine—multiple sclerosis	0.000657	0.0019	CcSEcCtD
Triazolam—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000657	0.0019	CcSEcCtD
Triazolam—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000653	0.00189	CcSEcCtD
Triazolam—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000651	0.00189	CcSEcCtD
Triazolam—Shock—Prednisolone—multiple sclerosis	0.000648	0.00188	CcSEcCtD
Triazolam—Tachycardia—Prednisolone—multiple sclerosis	0.000643	0.00186	CcSEcCtD
Triazolam—Hypertension—Triamcinolone—multiple sclerosis	0.000641	0.00186	CcSEcCtD
Triazolam—Hypertension—Methylprednisolone—multiple sclerosis	0.00064	0.00185	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000637	0.00185	CcSEcCtD
Triazolam—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000635	0.00184	CcSEcCtD
Triazolam—Vomiting—Azathioprine—multiple sclerosis	0.000632	0.00183	CcSEcCtD
Triazolam—Anxiety—Methylprednisolone—multiple sclerosis	0.000629	0.00182	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—multiple sclerosis	0.000628	0.00182	CcSEcCtD
Triazolam—Dermatitis—Azathioprine—multiple sclerosis	0.000626	0.00181	CcSEcCtD
Triazolam—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000625	0.00181	CcSEcCtD
Triazolam—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000625	0.00181	CcSEcCtD
Triazolam—Discomfort—Triamcinolone—multiple sclerosis	0.000625	0.00181	CcSEcCtD
Triazolam—Discomfort—Methylprednisolone—multiple sclerosis	0.000623	0.00181	CcSEcCtD
Triazolam—Headache—Azathioprine—multiple sclerosis	0.000623	0.0018	CcSEcCtD
Triazolam—Dry mouth—Triamcinolone—multiple sclerosis	0.000618	0.00179	CcSEcCtD
Triazolam—CYP3A4—nervous system—multiple sclerosis	0.000612	0.00209	CbGeAlD
Triazolam—Stomatitis—Methotrexate—multiple sclerosis	0.000612	0.00177	CcSEcCtD
Triazolam—Confusional state—Methylprednisolone—multiple sclerosis	0.00061	0.00177	CcSEcCtD
Triazolam—Malaise—Betamethasone—multiple sclerosis	0.000608	0.00176	CcSEcCtD
Triazolam—Malaise—Dexamethasone—multiple sclerosis	0.000608	0.00176	CcSEcCtD
Triazolam—Oedema—Triamcinolone—multiple sclerosis	0.000606	0.00176	CcSEcCtD
Triazolam—Syncope—Betamethasone—multiple sclerosis	0.000604	0.00175	CcSEcCtD
Triazolam—Syncope—Dexamethasone—multiple sclerosis	0.000604	0.00175	CcSEcCtD
Triazolam—Shock—Triamcinolone—multiple sclerosis	0.000596	0.00173	CcSEcCtD
Triazolam—Insomnia—Prednisolone—multiple sclerosis	0.000596	0.00173	CcSEcCtD
Triazolam—Shock—Methylprednisolone—multiple sclerosis	0.000595	0.00172	CcSEcCtD
Triazolam—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000592	0.00172	CcSEcCtD
Triazolam—Loss of consciousness—Betamethasone—multiple sclerosis	0.000592	0.00172	CcSEcCtD
Triazolam—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000592	0.00171	CcSEcCtD
Triazolam—Paraesthesia—Prednisolone—multiple sclerosis	0.000592	0.00171	CcSEcCtD
Triazolam—Tachycardia—Triamcinolone—multiple sclerosis	0.000591	0.00171	CcSEcCtD
Triazolam—Nausea—Azathioprine—multiple sclerosis	0.00059	0.00171	CcSEcCtD
Triazolam—Tachycardia—Methylprednisolone—multiple sclerosis	0.00059	0.00171	CcSEcCtD
Triazolam—CYP3A4—central nervous system—multiple sclerosis	0.00059	0.00201	CbGeAlD
Triazolam—Erythema—Prednisone—multiple sclerosis	0.000587	0.0017	CcSEcCtD
Triazolam—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000586	0.0017	CcSEcCtD
Triazolam—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000585	0.00169	CcSEcCtD
Triazolam—Hypertension—Betamethasone—multiple sclerosis	0.000582	0.00169	CcSEcCtD
Triazolam—Hypertension—Dexamethasone—multiple sclerosis	0.000582	0.00169	CcSEcCtD
Triazolam—Asthenia—Mitoxantrone—multiple sclerosis	0.000576	0.00167	CcSEcCtD
Triazolam—Anxiety—Betamethasone—multiple sclerosis	0.000572	0.00166	CcSEcCtD
Triazolam—Anxiety—Dexamethasone—multiple sclerosis	0.000572	0.00166	CcSEcCtD
Triazolam—Discomfort—Dexamethasone—multiple sclerosis	0.000567	0.00164	CcSEcCtD
Triazolam—Discomfort—Betamethasone—multiple sclerosis	0.000567	0.00164	CcSEcCtD
Triazolam—Pain—Prednisolone—multiple sclerosis	0.000564	0.00163	CcSEcCtD
Triazolam—Oedema—Betamethasone—multiple sclerosis	0.00055	0.00159	CcSEcCtD
Triazolam—Oedema—Dexamethasone—multiple sclerosis	0.00055	0.00159	CcSEcCtD
Triazolam—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00055	0.00159	CcSEcCtD
Triazolam—Insomnia—Triamcinolone—multiple sclerosis	0.000548	0.00159	CcSEcCtD
Triazolam—Insomnia—Methylprednisolone—multiple sclerosis	0.000547	0.00158	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisone—multiple sclerosis	0.000544	0.00158	CcSEcCtD
Triazolam—Paraesthesia—Triamcinolone—multiple sclerosis	0.000544	0.00158	CcSEcCtD
Triazolam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000543	0.00157	CcSEcCtD
Triazolam—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000543	0.00157	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—multiple sclerosis	0.000543	0.00157	CcSEcCtD
Triazolam—Shock—Dexamethasone—multiple sclerosis	0.000541	0.00157	CcSEcCtD
Triazolam—Shock—Betamethasone—multiple sclerosis	0.000541	0.00157	CcSEcCtD
Triazolam—Dyspnoea—Triamcinolone—multiple sclerosis	0.00054	0.00157	CcSEcCtD
Triazolam—Agitation—Prednisone—multiple sclerosis	0.000539	0.00156	CcSEcCtD
Triazolam—Tachycardia—Dexamethasone—multiple sclerosis	0.000537	0.00155	CcSEcCtD
Triazolam—Tachycardia—Betamethasone—multiple sclerosis	0.000537	0.00155	CcSEcCtD
Triazolam—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000532	0.00154	CcSEcCtD
Triazolam—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000532	0.00154	CcSEcCtD
Triazolam—Malaise—Prednisone—multiple sclerosis	0.000529	0.00153	CcSEcCtD
Triazolam—Syncope—Prednisone—multiple sclerosis	0.000526	0.00152	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—multiple sclerosis	0.000525	0.00152	CcSEcCtD
Triazolam—Anorexia—Betamethasone—multiple sclerosis	0.000524	0.00152	CcSEcCtD
Triazolam—Anorexia—Dexamethasone—multiple sclerosis	0.000524	0.00152	CcSEcCtD
Triazolam—Fatigue—Triamcinolone—multiple sclerosis	0.000523	0.00151	CcSEcCtD
Triazolam—Fatigue—Methylprednisolone—multiple sclerosis	0.000521	0.00151	CcSEcCtD
Triazolam—Pain—Triamcinolone—multiple sclerosis	0.000518	0.0015	CcSEcCtD
Triazolam—Loss of consciousness—Prednisone—multiple sclerosis	0.000516	0.00149	CcSEcCtD
Triazolam—Vomiting—Mitoxantrone—multiple sclerosis	0.000511	0.00148	CcSEcCtD
Triazolam—Hypertension—Prednisone—multiple sclerosis	0.000507	0.00147	CcSEcCtD
Triazolam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000506	0.00147	CcSEcCtD
Triazolam—Headache—Mitoxantrone—multiple sclerosis	0.000503	0.00146	CcSEcCtD
Triazolam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000499	0.00145	CcSEcCtD
Triazolam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000498	0.00144	CcSEcCtD
Triazolam—Anxiety—Prednisone—multiple sclerosis	0.000498	0.00144	CcSEcCtD
Triazolam—Insomnia—Dexamethasone—multiple sclerosis	0.000497	0.00144	CcSEcCtD
Triazolam—Insomnia—Betamethasone—multiple sclerosis	0.000497	0.00144	CcSEcCtD
Triazolam—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000494	0.00143	CcSEcCtD
Triazolam—Paraesthesia—Betamethasone—multiple sclerosis	0.000494	0.00143	CcSEcCtD
Triazolam—Paraesthesia—Dexamethasone—multiple sclerosis	0.000494	0.00143	CcSEcCtD
Triazolam—Discomfort—Prednisone—multiple sclerosis	0.000494	0.00143	CcSEcCtD
Triazolam—Erythema—Methotrexate—multiple sclerosis	0.00049	0.00142	CcSEcCtD
Triazolam—Hypersensitivity—Prednisolone—multiple sclerosis	0.000486	0.00141	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—multiple sclerosis	0.00048	0.00139	CcSEcCtD
Triazolam—Oedema—Prednisone—multiple sclerosis	0.000479	0.00139	CcSEcCtD
Triazolam—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000478	0.00138	CcSEcCtD
Triazolam—Decreased appetite—Betamethasone—multiple sclerosis	0.000478	0.00138	CcSEcCtD
Triazolam—Decreased appetite—Dexamethasone—multiple sclerosis	0.000478	0.00138	CcSEcCtD
Triazolam—Nausea—Mitoxantrone—multiple sclerosis	0.000477	0.00138	CcSEcCtD
Triazolam—Fatigue—Dexamethasone—multiple sclerosis	0.000474	0.00137	CcSEcCtD
Triazolam—Fatigue—Betamethasone—multiple sclerosis	0.000474	0.00137	CcSEcCtD
Triazolam—Shock—Prednisone—multiple sclerosis	0.000471	0.00136	CcSEcCtD
Triazolam—Pain—Dexamethasone—multiple sclerosis	0.00047	0.00136	CcSEcCtD
Triazolam—Pain—Betamethasone—multiple sclerosis	0.00047	0.00136	CcSEcCtD
Triazolam—Tachycardia—Prednisone—multiple sclerosis	0.000467	0.00135	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisone—multiple sclerosis	0.000463	0.00134	CcSEcCtD
Triazolam—Anorexia—Prednisone—multiple sclerosis	0.000456	0.00132	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000455	0.00132	CcSEcCtD
Triazolam—Feeling abnormal—Betamethasone—multiple sclerosis	0.000453	0.00131	CcSEcCtD
Triazolam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000453	0.00131	CcSEcCtD
Triazolam—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00045	0.0013	CcSEcCtD
Triazolam—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00045	0.0013	CcSEcCtD
Triazolam—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000447	0.00129	CcSEcCtD
Triazolam—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000446	0.00129	CcSEcCtD
Triazolam—Malaise—Methotrexate—multiple sclerosis	0.000442	0.00128	CcSEcCtD
Triazolam—Dizziness—Prednisolone—multiple sclerosis	0.000436	0.00126	CcSEcCtD
Triazolam—Asthenia—Triamcinolone—multiple sclerosis	0.000435	0.00126	CcSEcCtD
Triazolam—Abdominal pain—Dexamethasone—multiple sclerosis	0.000435	0.00126	CcSEcCtD
Triazolam—Abdominal pain—Betamethasone—multiple sclerosis	0.000435	0.00126	CcSEcCtD
Triazolam—Asthenia—Methylprednisolone—multiple sclerosis	0.000434	0.00126	CcSEcCtD
Triazolam—Insomnia—Prednisone—multiple sclerosis	0.000433	0.00125	CcSEcCtD
Triazolam—Paraesthesia—Prednisone—multiple sclerosis	0.00043	0.00125	CcSEcCtD
Triazolam—Pruritus—Triamcinolone—multiple sclerosis	0.000429	0.00124	CcSEcCtD
Triazolam—Pruritus—Methylprednisolone—multiple sclerosis	0.000428	0.00124	CcSEcCtD
Triazolam—Chest pain—Methotrexate—multiple sclerosis	0.000417	0.00121	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—multiple sclerosis	0.000416	0.00121	CcSEcCtD
Triazolam—Dermatitis—Prednisolone—multiple sclerosis	0.000415	0.0012	CcSEcCtD
Triazolam—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000414	0.0012	CcSEcCtD
Triazolam—Fatigue—Prednisone—multiple sclerosis	0.000413	0.0012	CcSEcCtD
Triazolam—Headache—Prednisolone—multiple sclerosis	0.000413	0.0012	CcSEcCtD
Triazolam—Discomfort—Methotrexate—multiple sclerosis	0.000412	0.00119	CcSEcCtD
Triazolam—Constipation—Prednisone—multiple sclerosis	0.00041	0.00119	CcSEcCtD
Triazolam—Confusional state—Methotrexate—multiple sclerosis	0.000404	0.00117	CcSEcCtD
Triazolam—Dizziness—Triamcinolone—multiple sclerosis	0.000401	0.00116	CcSEcCtD
Triazolam—Dizziness—Methylprednisolone—multiple sclerosis	0.0004	0.00116	CcSEcCtD
Triazolam—Feeling abnormal—Prednisone—multiple sclerosis	0.000395	0.00114	CcSEcCtD
Triazolam—Asthenia—Betamethasone—multiple sclerosis	0.000395	0.00114	CcSEcCtD
Triazolam—Asthenia—Dexamethasone—multiple sclerosis	0.000395	0.00114	CcSEcCtD
Triazolam—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000392	0.00113	CcSEcCtD
Triazolam—Nausea—Prednisolone—multiple sclerosis	0.000391	0.00113	CcSEcCtD
Triazolam—Pruritus—Dexamethasone—multiple sclerosis	0.000389	0.00113	CcSEcCtD
Triazolam—Pruritus—Betamethasone—multiple sclerosis	0.000389	0.00113	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000387	0.00112	CcSEcCtD
Triazolam—Vomiting—Triamcinolone—multiple sclerosis	0.000385	0.00112	CcSEcCtD
Triazolam—Vomiting—Methylprednisolone—multiple sclerosis	0.000384	0.00111	CcSEcCtD
Triazolam—Dermatitis—Triamcinolone—multiple sclerosis	0.000382	0.00111	CcSEcCtD
Triazolam—Anorexia—Methotrexate—multiple sclerosis	0.000382	0.00111	CcSEcCtD
Triazolam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000381	0.0011	CcSEcCtD
Triazolam—Headache—Triamcinolone—multiple sclerosis	0.00038	0.0011	CcSEcCtD
Triazolam—Headache—Methylprednisolone—multiple sclerosis	0.000379	0.0011	CcSEcCtD
Triazolam—Abdominal pain—Prednisone—multiple sclerosis	0.000379	0.0011	CcSEcCtD
Triazolam—Diarrhoea—Betamethasone—multiple sclerosis	0.000376	0.00109	CcSEcCtD
Triazolam—Diarrhoea—Dexamethasone—multiple sclerosis	0.000376	0.00109	CcSEcCtD
Triazolam—Dizziness—Dexamethasone—multiple sclerosis	0.000364	0.00105	CcSEcCtD
Triazolam—Dizziness—Betamethasone—multiple sclerosis	0.000364	0.00105	CcSEcCtD
Triazolam—Insomnia—Methotrexate—multiple sclerosis	0.000362	0.00105	CcSEcCtD
Triazolam—Nausea—Triamcinolone—multiple sclerosis	0.00036	0.00104	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—multiple sclerosis	0.000359	0.00104	CcSEcCtD
Triazolam—Nausea—Methylprednisolone—multiple sclerosis	0.000359	0.00104	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—multiple sclerosis	0.000357	0.00103	CcSEcCtD
Triazolam—Somnolence—Methotrexate—multiple sclerosis	0.000356	0.00103	CcSEcCtD
Triazolam—Hypersensitivity—Prednisone—multiple sclerosis	0.000353	0.00102	CcSEcCtD
Triazolam—Vomiting—Dexamethasone—multiple sclerosis	0.00035	0.00101	CcSEcCtD
Triazolam—Vomiting—Betamethasone—multiple sclerosis	0.00035	0.00101	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—multiple sclerosis	0.000348	0.00101	CcSEcCtD
Triazolam—Dermatitis—Dexamethasone—multiple sclerosis	0.000346	0.001	CcSEcCtD
Triazolam—Dermatitis—Betamethasone—multiple sclerosis	0.000346	0.001	CcSEcCtD
Triazolam—Fatigue—Methotrexate—multiple sclerosis	0.000345	0.001	CcSEcCtD
Triazolam—Headache—Betamethasone—multiple sclerosis	0.000344	0.000998	CcSEcCtD
Triazolam—Headache—Dexamethasone—multiple sclerosis	0.000344	0.000998	CcSEcCtD
Triazolam—Asthenia—Prednisone—multiple sclerosis	0.000344	0.000995	CcSEcCtD
Triazolam—Pain—Methotrexate—multiple sclerosis	0.000342	0.000991	CcSEcCtD
Triazolam—Pruritus—Prednisone—multiple sclerosis	0.000339	0.000981	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—multiple sclerosis	0.00033	0.000955	CcSEcCtD
Triazolam—Diarrhoea—Prednisone—multiple sclerosis	0.000328	0.000949	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000327	0.000948	CcSEcCtD
Triazolam—Nausea—Dexamethasone—multiple sclerosis	0.000327	0.000946	CcSEcCtD
Triazolam—Nausea—Betamethasone—multiple sclerosis	0.000327	0.000946	CcSEcCtD
Triazolam—Dizziness—Prednisone—multiple sclerosis	0.000317	0.000917	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—multiple sclerosis	0.000316	0.000916	CcSEcCtD
Triazolam—Vomiting—Prednisone—multiple sclerosis	0.000304	0.000882	CcSEcCtD
Triazolam—Dermatitis—Prednisone—multiple sclerosis	0.000302	0.000874	CcSEcCtD
Triazolam—Headache—Prednisone—multiple sclerosis	0.0003	0.000869	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—multiple sclerosis	0.000295	0.000854	CcSEcCtD
Triazolam—Asthenia—Methotrexate—multiple sclerosis	0.000287	0.000832	CcSEcCtD
Triazolam—Nausea—Prednisone—multiple sclerosis	0.000284	0.000824	CcSEcCtD
Triazolam—Pruritus—Methotrexate—multiple sclerosis	0.000283	0.00082	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—multiple sclerosis	0.000274	0.000793	CcSEcCtD
Triazolam—Dizziness—Methotrexate—multiple sclerosis	0.000265	0.000767	CcSEcCtD
Triazolam—Vomiting—Methotrexate—multiple sclerosis	0.000254	0.000737	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—multiple sclerosis	0.000252	0.00073	CcSEcCtD
Triazolam—Headache—Methotrexate—multiple sclerosis	0.000251	0.000726	CcSEcCtD
Triazolam—Nausea—Methotrexate—multiple sclerosis	0.000238	0.000689	CcSEcCtD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.45e-05	0.00595	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.45e-05	0.00595	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.12e-05	0.00501	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.99e-05	0.00493	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.87e-05	0.00484	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.87e-05	0.00484	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.79e-05	0.00478	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.79e-05	0.00478	CbGpPWpGaD
Triazolam—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.78e-05	0.00478	CbGpPWpGaD
Triazolam—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.78e-05	0.00478	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	6.67e-05	0.0047	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.67e-05	0.0047	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.67e-05	0.0047	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	6.37e-05	0.00449	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	6.37e-05	0.00449	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.28e-05	0.00442	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.28e-05	0.00442	CbGpPWpGaD
Triazolam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	6.17e-05	0.00435	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.59e-05	0.00394	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.57e-05	0.00393	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.57e-05	0.00393	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	5.51e-05	0.00389	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	5.51e-05	0.00389	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.51e-05	0.00388	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.49e-05	0.00387	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.44e-05	0.00383	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.44e-05	0.00383	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.41e-05	0.00381	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.39e-05	0.0038	CbGpPWpGaD
Triazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.37e-05	0.00379	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—BCHE—multiple sclerosis	5.36e-05	0.00377	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	5.3e-05	0.00374	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.21e-05	0.00367	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.15e-05	0.00363	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.15e-05	0.00363	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.15e-05	0.00363	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.12e-05	0.00361	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—BCHE—multiple sclerosis	5.11e-05	0.0036	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—BCHE—multiple sclerosis	5.11e-05	0.0036	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.05e-05	0.00356	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.71e-05	0.00332	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.62e-05	0.00326	CbGpPWpGaD
Triazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.6e-05	0.00324	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.57e-05	0.00322	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.49e-05	0.00316	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.49e-05	0.00316	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	4.49e-05	0.00316	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	4.49e-05	0.00316	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.43e-05	0.00312	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.43e-05	0.00312	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.41e-05	0.00311	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.41e-05	0.00311	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.38e-05	0.00309	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.33e-05	0.00305	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.31e-05	0.00303	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.3e-05	0.00303	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	4.29e-05	0.00302	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.26e-05	0.003	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.24e-05	0.00299	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.23e-05	0.00298	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—BCHE—multiple sclerosis	4.21e-05	0.00297	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.17e-05	0.00294	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—BCHE—multiple sclerosis	4.14e-05	0.00292	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.07e-05	0.00287	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.07e-05	0.00287	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.95e-05	0.00278	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—BCHE—multiple sclerosis	3.92e-05	0.00276	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.9e-05	0.00275	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—BCHE—multiple sclerosis	3.87e-05	0.00273	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	3.81e-05	0.00268	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.77e-05	0.00266	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.76e-05	0.00265	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.73e-05	0.00263	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	3.7e-05	0.0026	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.6e-05	0.00253	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.6e-05	0.00253	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.57e-05	0.00251	CbGpPWpGaD
Triazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.54e-05	0.0025	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—BCHE—multiple sclerosis	3.54e-05	0.0025	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.46e-05	0.00244	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.45e-05	0.00243	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—BCHE—multiple sclerosis	3.44e-05	0.00242	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.4e-05	0.0024	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—BCHE—multiple sclerosis	3.38e-05	0.00238	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.35e-05	0.00236	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.34e-05	0.00236	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.33e-05	0.00234	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.32e-05	0.00234	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—BCHE—multiple sclerosis	3.32e-05	0.00234	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.3e-05	0.00232	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—BCHE—multiple sclerosis	3.3e-05	0.00232	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.3e-05	0.00232	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.26e-05	0.0023	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—BCHE—multiple sclerosis	3.24e-05	0.00228	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.12e-05	0.0022	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.08e-05	0.00217	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.96e-05	0.00209	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	2.96e-05	0.00209	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	2.96e-05	0.00209	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.92e-05	0.00206	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.92e-05	0.00206	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.92e-05	0.00206	CbGpPWpGaD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.88e-05	0.00203	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.85e-05	0.00201	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—BCHE—multiple sclerosis	2.83e-05	0.002	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.82e-05	0.00199	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.76e-05	0.00194	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.74e-05	0.00193	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.72e-05	0.00192	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.72e-05	0.00192	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.7e-05	0.0019	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.69e-05	0.0019	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.64e-05	0.00186	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.63e-05	0.00185	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.59e-05	0.00183	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.59e-05	0.00183	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.58e-05	0.00182	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.49e-05	0.00176	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.42e-05	0.00171	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.38e-05	0.00168	CbGpPWpGaD
Triazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.34e-05	0.00165	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.34e-05	0.00165	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.34e-05	0.00165	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.32e-05	0.00164	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.28e-05	0.00161	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.25e-05	0.00159	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SRM—multiple sclerosis	2.14e-05	0.00151	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.14e-05	0.0015	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.12e-05	0.00149	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.12e-05	0.00149	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.1e-05	0.00148	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.04e-05	0.00144	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.99e-05	0.0014	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.99e-05	0.0014	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—POMC—multiple sclerosis	1.98e-05	0.0014	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.96e-05	0.00138	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.95e-05	0.00137	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.95e-05	0.00137	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.9e-05	0.00134	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	1.8e-05	0.00127	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.8e-05	0.00127	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.75e-05	0.00123	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.73e-05	0.00122	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.72e-05	0.00121	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.72e-05	0.00121	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.71e-05	0.00121	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.68e-05	0.00119	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.67e-05	0.00118	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.64e-05	0.00116	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	1.64e-05	0.00115	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.61e-05	0.00113	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.58e-05	0.00111	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—MAPK1—multiple sclerosis	1.57e-05	0.0011	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.55e-05	0.00109	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SRM—multiple sclerosis	1.55e-05	0.00109	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	1.51e-05	0.00106	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	1.51e-05	0.00106	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.5e-05	0.00105	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—MAPK1—multiple sclerosis	1.49e-05	0.00105	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—MAPK1—multiple sclerosis	1.49e-05	0.00105	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.48e-05	0.00104	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.44e-05	0.00101	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.43e-05	0.00101	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPC5—multiple sclerosis	1.38e-05	0.000971	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.36e-05	0.000956	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.35e-05	0.000952	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SRM—multiple sclerosis	1.34e-05	0.000943	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.31e-05	0.000925	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.29e-05	0.000912	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.29e-05	0.000912	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.29e-05	0.000908	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.27e-05	0.000893	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.26e-05	0.000887	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.25e-05	0.000884	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.25e-05	0.000883	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.24e-05	0.000874	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.24e-05	0.000871	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—MAPK1—multiple sclerosis	1.23e-05	0.000867	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—MAPK1—multiple sclerosis	1.21e-05	0.000854	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—MAPK1—multiple sclerosis	1.15e-05	0.000808	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000804	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—MAPK1—multiple sclerosis	1.13e-05	0.000798	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SRM—multiple sclerosis	1.09e-05	0.000768	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.09e-05	0.000767	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.09e-05	0.000767	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.08e-05	0.000761	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.07e-05	0.000751	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.05e-05	0.00074	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MAPK1—multiple sclerosis	1.04e-05	0.000729	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.01e-05	0.000713	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.01e-05	0.000711	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MAPK1—multiple sclerosis	1.01e-05	0.000709	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPC5—multiple sclerosis	9.96e-06	0.000702	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.94e-06	0.0007	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MAPK1—multiple sclerosis	9.88e-06	0.000696	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.81e-06	0.000691	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MAPK1—multiple sclerosis	9.7e-06	0.000684	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MAPK1—multiple sclerosis	9.64e-06	0.000679	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MAPK1—multiple sclerosis	9.47e-06	0.000667	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	9.43e-06	0.000665	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	9.43e-06	0.000665	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.22e-06	0.00065	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.97e-06	0.000632	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.72e-06	0.000614	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPC5—multiple sclerosis	8.63e-06	0.000608	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.56e-06	0.000603	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.41e-06	0.000593	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.36e-06	0.000589	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	8.28e-06	0.000583	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—RRM1—multiple sclerosis	8.25e-06	0.000581	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.21e-06	0.000578	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	7.68e-06	0.000541	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	7.68e-06	0.000541	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.5e-06	0.000529	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SRM—multiple sclerosis	7.18e-06	0.000506	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.17e-06	0.000505	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RRM1—multiple sclerosis	7.15e-06	0.000504	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPC5—multiple sclerosis	7.02e-06	0.000495	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.66e-06	0.000469	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BCHE—multiple sclerosis	6.56e-06	0.000462	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.82e-06	0.00041	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.55e-06	0.000391	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.06e-06	0.000357	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.06e-06	0.000357	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.76e-06	0.000336	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCHE—multiple sclerosis	4.74e-06	0.000334	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.63e-06	0.000326	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.51e-06	0.000318	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.34e-06	0.000306	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCHE—multiple sclerosis	4.11e-06	0.000289	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—multiple sclerosis	3.94e-06	0.000278	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.88e-06	0.000273	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.84e-06	0.00027	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.53e-06	0.000249	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—multiple sclerosis	3.39e-06	0.000239	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.34e-06	0.000235	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—multiple sclerosis	3.09e-06	0.000218	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—multiple sclerosis	2.85e-06	0.000201	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—multiple sclerosis	2.47e-06	0.000174	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—multiple sclerosis	2.45e-06	0.000173	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—multiple sclerosis	2.23e-06	0.000157	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.2e-06	0.000155	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—multiple sclerosis	2.12e-06	0.000149	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—multiple sclerosis	2.01e-06	0.000142	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—multiple sclerosis	1.93e-06	0.000136	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—multiple sclerosis	1.73e-06	0.000122	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—multiple sclerosis	1.57e-06	0.000111	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—multiple sclerosis	1.33e-06	9.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—multiple sclerosis	1.14e-06	8.02e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—multiple sclerosis	1.04e-06	7.32e-05	CbGpPWpGaD
